GH and Cardiovascular Risk Factors
NCT01877512
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Growth Hormone Deficiency
Cardiovascular Diseases
Metabolic Syndrome
Cognition
Physical Activity
Interventions
DRUG:
Change in daily dosage of Growth Hormone
Sponsor
Amsterdam UMC, location VUmc